Literature DB >> 21703242

The presence of 5-hydroxymethylcytosine at the gene promoter and not in the gene body negatively regulates gene expression.

Julia Robertson1, Adam B Robertson, Arne Klungland.   

Abstract

5-Hydroxymethylcytosine (5hmC) was recently described as a stable modification in mammalian DNA. 5hmC is formed by the enzymatic oxidation of 5-methylcytosine (5meC). Overwhelming evidence supports the notion that 5meC has a negative effect on transcription; however, only recently has the effect that 5hmC has on transcription begun to be studied. Using model substrates including the CMV(IE) promoter and a generic gene body we have directly assessed the effect that 5hmC, both at the promoter and in the gene body, has on in vitro gene transcription. We show that the presence of the 5hmC modifications strongly represses transcription. We also demonstrate that the inhibition of transcriptional activity is primarily due to the presence of 5hmC in the promoter and that 5hmC in the gene body has a minimal effect on transcription. Thus, we propose that the presence of 5hmC in promoter prevents the binding of essential transcription factors or recruits factors that repress transcription.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703242     DOI: 10.1016/j.bbrc.2011.06.077

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

1.  Next-generation sequencing reveals regional differences of the α-synuclein methylation state independent of Lewy body disease.

Authors:  L de Boni; S Tierling; S Roeber; J Walter; A Giese; Hans A Kretzschmar
Journal:  Neuromolecular Med       Date:  2011-11-01       Impact factor: 3.843

2.  Genome-wide mapping of 5-hydroxymethylcytosine in three rice cultivars reveals its preferential localization in transcriptionally silent transposable element genes.

Authors:  Xi-liang Wang; Shu-hui Song; Yong-Sheng Wu; Yu-Li Li; Ting-ting Chen; Zhi-yuan Huang; Shuo Liu; Thomas L Dunwell; Gerd P Pfeifer; Jim M Dunwell; Raheema Wamaedeesa; Ihsan Ullah; Yinsheng Wang; Song-nian Hu
Journal:  J Exp Bot       Date:  2015-08-13       Impact factor: 6.992

3.  Pull-down of 5-hydroxymethylcytosine DNA using JBP1-coated magnetic beads.

Authors:  Adam B Robertson; John Arne Dahl; Rune Ougland; Arne Klungland
Journal:  Nat Protoc       Date:  2012-01-26       Impact factor: 13.491

4.  Epigenetic changes in the progression of Alzheimer's disease.

Authors:  M A Bradley-Whitman; M A Lovell
Journal:  Mech Ageing Dev       Date:  2013-09-03       Impact factor: 5.432

Review 5.  Common stemness regulators of embryonic and cancer stem cells.

Authors:  Christiana Hadjimichael; Konstantina Chanoumidou; Natalia Papadopoulou; Panagiota Arampatzi; Joseph Papamatheakis; Androniki Kretsovali
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

6.  Role of TET2 mutations in myeloproliferative neoplasms.

Authors:  Elodie Pronier; François Delhommeau
Journal:  Curr Hematol Malig Rep       Date:  2012-03       Impact factor: 3.952

Review 7.  Active DNA demethylation in post-mitotic neurons: a reason for optimism.

Authors:  David P Gavin; Kayla A Chase; Rajiv P Sharma
Journal:  Neuropharmacology       Date:  2013-08-16       Impact factor: 5.250

Review 8.  Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation.

Authors:  Hao Wu; Yi Zhang
Journal:  Genes Dev       Date:  2011-12-01       Impact factor: 11.361

9.  Effect of Hydroxymethylcytosine on the Structure and Stability of Holliday Junctions.

Authors:  Crystal M Vander Zanden; Rhianon K Rowe; Amanda J Broad; Adam B Robertson; P Shing Ho
Journal:  Biochemistry       Date:  2016-10-05       Impact factor: 3.162

Review 10.  Insight from animal models of environmentally driven epigenetic changes in the developing and adult brain.

Authors:  Tiffany S Doherty; Tania L Roth
Journal:  Dev Psychopathol       Date:  2016-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.